Learn about the founding of MNS

Leeds x MNS

Located in the Nexus building at the University of Leeds, in the heart of a dynamic health tech cluster in West Yorkshire.

At MNS, we are proud to be situated at the epicentre of health technology advancement in the heart of the North of England in West Yorkshire. Our home is the Nexus building, a vibrant and cutting-edge facility within the esteemed University of Leeds campus. This strategic location places us right in the heart of a dynamic health tech cluster, surrounded by an atmosphere of innovation and discovery.

A lobby with a television and a large sign on the wall.
A large library filled with lots of books.

From Academic Theory to Transformative Practice

As students navigating their academic and personal lives through the pandemic, they observed the significant health disparities exacerbated by the crisis. The challenges in vaccine delivery, particularly in remote and underserved areas, highlighted a glaring gap in the healthcare system. Determined to address this, they combined their expertise and insights gained at the University of Leeds to develop an innovative solution - the MNS vaccine patch.

Looking Towards a Healthier Future

Today, MNS stands as a beacon of innovation and social responsibility, driven by the vision of its founders to create a more equitable world in healthcare. From their university beginnings to the forefront of medical technology, MNS continues to strive towards a future where health disparities are significantly reduced, and quality healthcare is a universal reality.

Learn more

Meet our team members

The founders and management team of
MNS

- "Henry Dunne is the CEO and co-founder of MNS. He founded the company during his second year at the University of Leeds while studying Biotechnology with Enterprise. Henry's early vision and entrepreneurial spirit have driven MNS to the forefront of medical technology innovation, where the company continues to revolutionize drug delivery systems and enhance patient care."

- "Ian is the CTO and co-founder of MNS. Alongside Henry, he co-founded the company during their undergraduate studies, developing groundbreaking technology from his dorm room. Ian's technical expertise and innovative drive have been instrumental in advancing MNS's cutting-edge solutions in drug delivery and patient care."

Dr. David Pearce is a seasoned entrepreneur, angel investor, and former NHS clinician. With a successful track record in founding and exiting two SaaS companies, David brings invaluable expertise to MNS. His experience as an NHS clinician provides essential insights into patient needs and regulatory aspects.

- "Dr. Glenn Crocker is a leader in biotechnology with a DPhil in Immunology from the University of Oxford. He founded and led BioCity Group and has held key roles in several successful life sciences companies. Awarded an MBE for his services to biotechnology, Glenn combines scientific and financial expertise, having been Head of UK Biotechnology at Ernst & Young. As a Non-Executive Director at MNS, Glenn brings invaluable experience in biotech startups, strategic investment, and corporate governance, essential for advancing MNS's innovative vaccine patch development."

A man standing in front of a table with a bottle on it.

Henry Dunne

Co-founder
& CEO
A man standing in front of a blue wall.

Ian Bartenev

Co-founder
& CTO
A man wearing glasses and a white shirt.

Dr David Pearce

Non executive director
A man wearing a suit and blue shirt.

Dr Glenn Crocker

Non executive director